La farmacéutica Roche ha desarrollado una terapia contra el cáncer de mama que podría suponer un antes y un después en el tratamiento de esta enfermedad, y que consite en un agente biológico que hace de ‘caballo de Troya’ o ‘misil teledirigido’. Más
- A mathematical model for HIV dynamics with multiple infections: implications for immune escape 19/05/2024
- Prevalence of Age-Related Macular Degeneration in Patients with Chronic Exposure to P2X7R Inhibitors 18/05/2024
- Distinct patterns of cigarette smoking intensity and other substance use among women who experience housing instability 18/05/2024
- Seroprevalence of Treponema pallidum infection among high-risk populations from Brazil 18/05/2024
- Drug-Drug Interactions between Antiretrovirals and Hormonal Contraception: An Updated Systematic Review 18/05/2024
 |
 |
 |
 |
- Better medical record-keeping needed to fight antibiotic overuse 17/05/2024
- Global life expectancy to increase by nearly 5 years by 2050 despite geopolitical, metabolic, and environmental threats 17/05/2024
- Clinicians report success with first test of drug in a patient with life-threatening blood clotting disorder 17/05/2024
- Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses 17/05/2024
- Sweet taste receptor affects how glucose is handled metabolically by humans 17/05/2024
 |
19 de mayo de 2024
| Sitio presentado el 18 de mayo de 2010 |  |
DE NUESTROS LECTORES